Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis

Abstract

Budesonide is a highly effective and well tolerated treatment of collagenous colitis. There is a high risk of relapse after stopping eight weeks of treatment.